Core Insights - The synthetic biology manufacturing industry in China is experiencing rapid growth, with a projected market size nearing 80 billion yuan in 2024 and expected to approach 100 billion yuan in 2025, reflecting a growth rate of 26.2% compared to 2024 [1] - The industry has maintained a growth rate of over 25% for the past three years, driven by policy incentives and technological breakthroughs, leading to accelerated commercialization and increased market acceptance [1] Industry Overview - The primary products in China's synthetic biology manufacturing sector are currently biopharmaceuticals, which are expected to reach a market size of 33.43 billion yuan in 2024, accounting for 42.9% of the total industry [1] - The demand for biopharmaceutical products is anticipated to rise further due to the ongoing development of new therapies, such as cell and gene therapies, which will contribute to an increase in both product quantity and market demand [1] Future Projections - The synthetic biology manufacturing industry in China is projected to exceed 100 billion yuan by 2026 and reach approximately 170.37 billion yuan by 2027 [1]
机构报告：预计2026年中国合成生物制造产业规模将突破千亿
Xin Hua Cai Jing·2026-01-20 07:55